Today's Low
₹ 106.50
Today's High
₹ 109.70
52 Weeks Low
₹ 97.10
52 Weeks High
₹ 180.00
Lower
₹ 86.35
Upper
₹ 129.45
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical and additive blend products in India, Mexico, Central and North America, China, Europe, Singapore, and South America. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate, as well as natural shelf life solution products, such as tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life for food and feed industry under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin under the Vanesse and Evanil brands; and nutraceutical products from fermentation and green extraction sources comprising algal carotenoids, natural colors and vitamins, minerals and proteins, cosmetic ingredients, organic herbals, and probiotics. In addition, it offers performance chemicals, such as hydroquinone and catechol; and downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, ODEB, CME, HQEE, etc. Further, the company manufactures and markets various animal nutrition products, antioxidants, adsorbents, acidifying agents, antimicrobials, bactericides, sanitizers, growth promoters, toxin and pellet binders, and mold inhibitors. It also exports its products. Its products are used in food and beverage, pet food and animal nutrition, rendering, aquaculture, biodiesel, flavor and fragrance, pharmaceutical, petrochemical, agrochemical, dyes and pigment, polymers, textile, printing, household and industrial products, telecommunications, and oil and gas industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1,085.8 | 891.5 | 794.7 | 675.0 | 672.5 | 665.6 | 419.4 | 299.7 | 298.7 | 256.8 | 283.2 | 206.9 |
Total Non-Current Assets | 942.3 | 870.2 | 653.9 | 518.4 | 373.1 | 311.4 | 229.0 | 168.1 | 114.5 | 107.9 | 86.3 | 78.7 |
Total Assets | 2,030.1 | 1,763.7 | 1,448.6 | 1,193.4 | 1,045.6 | 976.9 | 648.4 | 467.9 | 413.2 | 364.7 | 369.5 | 285.6 |
Total Current Liabilities | 793.0 | 595.3 | 477.6 | 547.8 | 460.4 | 470.9 | 385.7 | 279.9 | 261.5 | 245.9 | 263.3 | 196.4 |
Total Non-Current Liabilities | 413.1 | 403.4 | 257.8 | 185.4 | 154.9 | 72.6 | 32.5 | 11.7 | 16.8 | 25.5 | 40.8 | 36.3 |
Shareholder's Funds | 819.4 | 747.9 | 643.4 | 403.1 | 370.9 | 371.2 | 212.6 | 176.2 | 134.9 | 93.3 | 65.4 | 52.9 |
Total Liabilities | 2,030.1 | 1,763.7 | 1,448.6 | 1,193.4 | 1,045.6 | 976.9 | 648.4 | 467.9 | 413.2 | 364.7 | 369.5 | 285.6 |
The Industry Quick Ratio stands at 1.33, vs the Quick Ratio of 0.69, which results in a Negative aspect.
The Industry Current Ratio stands at 1.94, vs the Current Ratio of 1.23, which results in a Negative aspect.
The Industry Price to BV stands at 10.60, vs the Price to BV of 2.08, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.84, vs the Debt to Equity Ratio of 1.31, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 1,681.6 | 1,412.1 | 1,187.1 | 1,049.2 | 892.2 | 720.6 | 533.9 | 489.3 | 558.3 | 508.7 | 373.6 | 335.3 |
Total Expenditure | 1,471.3 | 1,257.9 | 1,000.4 | 913.9 | 819.3 | 706.0 | 503.2 | 397.6 | 474.1 | 449.2 | 327.6 | 306.2 |
Operating Profit(Excl OI) | 216.8 | 190.9 | 197.5 | 138.6 | 86.7 | 27.6 | 46.4 | 96.1 | 92.6 | 71.3 | 57.2 | 40.9 |
Add: Other Income | 6.4 | 36.7 | 10.8 | 3.4 | 13.8 | 12.9 | 15.7 | 4.3 | 8.4 | 11.8 | 11.2 | 11.8 |
Operating Profit | 216.8 | 190.9 | 197.5 | 138.6 | 86.7 | 27.6 | 46.4 | 96.1 | 92.6 | 71.3 | 57.2 | 40.9 |
Less: Interest | 64.2 | 40.8 | 48.1 | 47.6 | 41.0 | 31.8 | 30.6 | 24.4 | 23.8 | 24.7 | 20.1 | 16.7 |
PBDT | 152.6 | 150.1 | 149.4 | 91.0 | 45.7 | -4.2 | 15.8 | 71.6 | 68.7 | 46.7 | 37.1 | 24.2 |
Less: Depreciation Amortization | 62.5 | 56.0 | 44.3 | 32.8 | 29.0 | 26.7 | 21.8 | 17.1 | 16.3 | 11.8 | 13.6 | 13.5 |
PBT & Exceptional Items | 90.1 | 94.1 | 105.1 | 58.2 | 16.8 | -30.9 | -6.0 | 54.6 | 52.5 | 34.9 | 23.5 | 10.7 |
Less: Exceptional Income Expenses | -9.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.6 | 0.4 | 0.0 | 0.0 | 0.2 |
Profit Before Tax | 80.4 | 94.0 | 105.1 | 58.2 | 16.8 | -30.9 | -6.0 | 50.0 | 52.8 | 34.9 | 23.5 | 10.8 |
Less: Taxation | 40.6 | 33.6 | 39.7 | 28.4 | 13.7 | -6.8 | -1.6 | 14.2 | -2.2 | 6.1 | 8.4 | 6.9 |
Profit After Tax | 39.8 | 60.4 | 65.4 | 29.8 | 3.1 | -24.1 | -4.5 | 35.8 | 55.0 | 28.7 | 15.1 | 3.9 |
Earnings Per Share | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
The Industry PE Ratio stands at 59.04, vs the PE Ratio of 0.00, which results in a Negative aspect.
The Industry PAT Margin stands at 13.10, vs the PAT Margin of 2.84, which results in a Negative aspect.
The Industry PAT Growth stands at 40.72, vs the PAT Growth of 873.43, which results in a Positive aspect.
The Industry Dividend Yield stands at 0.47, vs the Dividend Yield of 0.00, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 80.4 | 94.0 | 105.1 | 58.2 | 16.7 | -30.9 | -6.0 | 50.0 | 52.5 | 34.9 | 23.5 | 10.7 |
Tax Paid | -20.2 | -30.4 | -35.9 | -17.9 | -16.2 | -10.1 | -10.4 | -12.2 | -10.9 | -9.7 | -6.4 | -5.2 |
Adjustment | 129.5 | 77.7 | 114.2 | 87.0 | 70.4 | 40.9 | 46.7 | 48.9 | 47.3 | 40.3 | 32.7 | 26.5 |
Changes In Working Capital | 80.4 | 94.0 | 105.1 | 58.2 | 16.7 | -30.9 | -6.0 | 50.0 | 52.5 | 34.9 | 23.5 | 10.7 |
Cash Flow after changes in Working Capital | 71.1 | 175.8 | 153.3 | 103.9 | 7.2 | -5.3 | 1.7 | 83.8 | 57.1 | 36.4 | 62.0 | -26.6 |
Cash Flow from Operating Activities | 50.9 | 145.4 | 117.4 | 86.0 | -9.0 | -15.4 | -8.7 | 71.6 | 46.3 | 26.7 | 55.6 | -31.9 |
Cash Flow from Investing Activities | -124.6 | -249.1 | -132.9 | -90.1 | -1.9 | -148.6 | -83.1 | -65.7 | -26.3 | -32.2 | -18.7 | -9.2 |
Cash Flow from Financing Activities | 59.7 | 136.0 | 38.6 | 3.3 | 25.7 | 181.8 | 90.9 | -6.9 | -15.5 | -6.3 | -21.4 | 38.2 |
Net Cash Inflow / Outflow | -14.1 | 32.3 | 23.2 | -0.8 | 14.7 | 17.8 | -0.9 | -1.0 | 4.5 | -11.7 | 15.5 | -2.9 |
Opening Cash & Cash Equivalents | 107.8 | 75.5 | 52.4 | 53.2 | 38.5 | 20.7 | 8.0 | 9.0 | 4.5 | 16.2 | 10.2 | 13.1 |
Closing Cash & Cash Equivalent | 93.7 | 107.8 | 75.5 | 52.4 | 53.2 | 38.5 | 20.7 | 8.0 | 9.0 | 4.5 | 25.7 | 10.2 |
The Industry PCF RATIO stands at 46.86, vs the PCF RATIO of 5.55, which results in a Negative aspect.
The Industry PFCF Ratio stands at 8.68, vs the PFCF Ratio of -4.24, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 3,858.9 | 4,058.8 | 4,196.0 | 4,267.1 | 3,878.4 | 4,832.5 | 3,837.8 | 3,892.3 | 3,808.2 | 3,112.2 | 3,308.3 | 3,266.2 | 2,979.3 | 2,568.1 | 3,057.4 | 2,928.7 |
Total Income | 3,875.5 | 4,076.4 | 4,259.7 | 4,287.1 | 3,976.0 | 4,861.2 | 3,848.0 | 4,105.4 | 3,864.0 | 3,118.4 | 3,413.8 | 3,287.2 | 3,023.4 | 2,580.9 | 3,064.1 | 2,956.4 |
Total Expenditure | 3,625.6 | 3,854.7 | 3,808.9 | 3,828.9 | 3,380.8 | 4,280.4 | 3,371.5 | 3,696.4 | 3,256.5 | 2,885.1 | 2,852.6 | 2,769.6 | 2,511.5 | 2,231.7 | 2,546.7 | 2,585.8 |
PBIDT (Excl OI) | 233.2 | 204.1 | 387.1 | 438.2 | 497.6 | 552.1 | 466.2 | 195.8 | 551.7 | 227.1 | 455.7 | 496.7 | 467.7 | 336.4 | 510.8 | 342.9 |
Other Income | 16.6 | 17.6 | 63.7 | 20.0 | 97.6 | 28.8 | 10.3 | 213.2 | 55.8 | 6.2 | 105.5 | 20.9 | 44.2 | 12.8 | 6.7 | 27.7 |
Operating Profit | 249.9 | 221.7 | 450.8 | 458.2 | 595.2 | 580.9 | 476.5 | 409.0 | 607.5 | 233.3 | 561.2 | 517.6 | 511.9 | 349.3 | 517.5 | 370.6 |
Interest | 141.4 | 150.5 | 102.2 | 97.8 | 115.5 | 184.5 | 187.3 | 50.1 | 68.2 | 90.6 | 101.3 | 113.3 | 100.2 | 81.3 | 107.6 | 152.3 |
Exceptional Items | 0.0 | 0.0 | 0.0 | -96.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 108.5 | 71.2 | 348.6 | 263.6 | 479.7 | 396.4 | 289.2 | 358.9 | 539.3 | 142.8 | 459.8 | 404.3 | 411.7 | 268.0 | 409.9 | 218.3 |
Depreciation | 205.8 | 192.0 | 187.8 | 179.3 | 161.8 | 140.2 | 143.7 | 159.4 | 132.5 | 133.7 | 134.1 | 118.3 | 133.6 | 96.3 | 94.8 | 91.3 |
Profit Before Tax | -97.3 | -120.9 | 160.8 | 84.3 | 317.9 | 256.2 | 145.5 | 199.5 | 406.9 | 9.1 | 325.7 | 286.0 | 278.1 | 171.7 | 315.1 | 127.1 |
Tax | 45.5 | 87.4 | 40.6 | 49.5 | 89.2 | 157.4 | 109.5 | 66.6 | 135.3 | 46.5 | 87.7 | 128.9 | 83.9 | 75.1 | 109.5 | 106.5 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | -142.8 | -208.3 | 120.2 | 34.8 | 228.6 | 98.7 | 36.0 | 132.9 | 271.5 | -37.4 | 238.0 | 157.2 | 194.2 | 96.6 | 205.6 | 20.5 |
Net Profit | -142.8 | -208.3 | 120.2 | 34.8 | 228.6 | 98.7 | 36.0 | 132.9 | 271.5 | -37.4 | 238.0 | 157.2 | 194.2 | 96.6 | 205.6 | 20.5 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 167.5 | 167.5 | 167.4 | 157.1 | 157.1 | 157.1 | 157.0 | 157.0 | 127.6 | 127.6 | 127.6 | 127.5 | 127.5 | 121.3 | 121.3 | 121.3 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | -0.7 | -1.2 | 1.0 | 0.6 | 1.5 | 0.8 | 0.4 | 1.2 | 2.3 | -0.4 | 1.8 | 1.2 | 1.3 | 0.5 | 1.3 | 0.2 |
Operating Profit Margin | 6.5 | 5.5 | 10.7 | 10.7 | 15.3 | 12.0 | 12.4 | 10.5 | 16.0 | 7.5 | 17.0 | 15.8 | 17.2 | 13.6 | 16.9 | 12.7 |
Net Profit Margin | -3.7 | -5.1 | 2.9 | 0.8 | 5.9 | 2.0 | 0.9 | 3.4 | 7.1 | -1.2 | 7.2 | 4.8 | 6.5 | 3.8 | 6.7 | 0.7 |
The Industry Net Sales Growth stands at 22.88, vs the Net Sales Growth of 17.60, which results in a Negative aspect.
The Industry Mcap Growth stands at 41.84, vs the Mcap Growth of -20.96, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 114.30 | 117.60 | 109.66 |
R3 | 112.77 | 112.70 | 108.78 |
R2 | 111.23 | 111.20 | 108.49 |
R1 | 109.57 | 109.50 | 108.19 |
Pivot | 108.03 | 108.00 | 108.03 |
S1 | 106.37 | 106.30 | 107.61 |
S2 | 104.83 | 104.80 | 107.31 |
S3 | 103.17 | 103.10 | 107.02 |
S4 | 101.50 | 98.40 | 106.14 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
98.85
Bearish
RSI
49.71
Neutral
ROC
20.90
Bullish
UltimateOscillator
52.75
Neutral
Williams Indicator
-12.53
Bearish
CCI Indicator
62.73
Neutral
MACD
-2,851.89
Bearish
Stochastic Indicator
86.65
Neutral
ATR
5.45
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
09-02-2024 | Quarterly Results |
06-11-2023 | Quarterly Results |
11-08-2023 | Quarterly Results |
22-05-2023 | Audited Results |
13-02-2023 | Quarterly Results |
12-11-2022 | Quarterly Results |
12-08-2022 | Quarterly Results |
19-05-2022 | Audited Results |
07-02-2022 | Quarterly Results |
12-11-2021 | Quarterly Results |
13-08-2021 | Quarterly Results |
28-05-2021 | Dividend & Audited Results |